Curtis Alexander Davey, Associate ProfessorAssociate Professor at the School of Biological Sciences, College of Science, NTU, Singapore is our next special guest speaker. His talk entitled “X-Ray Crystal Structure of a Chromatosome— the Fundamental Nucleosome-Linker Histone Assembly of Chromatin” will take place at EPF Lausanne.
Prof. Davey fundamental research interest focuses on understanding the structural and dynamical features of chromatin assembly and how this could yield unique therapeutic possibilities. Davey’s lab has analyzed nucleosome structure and stability with many different DNA fragments to derive a general mechanical model that helps explain and predict the sequence-dependent properties of this system. His lab studies how nucleosomes and chromatin fiber are recognized and influenced by metals, xenobiotics, drugs and therapeutic candidates as well as by nuclear proteins, such as DNA repair, apoptotic and developmental transcription factors. Davey’s lab is working on adduct structure, site selectivity, modulatory and reaction mechanism principles for a variety of chromatin-binding agents, such as metal-based anticancer agents, which, together with understanding how macromolecules recognize specific chromatin states, can reveal novel genomic regulatory features, and allow to engage in directed drug design.
- Z. Ma*, G. Palermo*, Z. Adhireksan*, B.S. Murray, T. von Erlach, P.J. Dyson, U. Rothlisberger & C.A. Davey. 2016. An Organometallic Compound which Exhibits a DNA Topology-Dependent One-Stranded Intercalation Mode. Angew. Chem. Int. Ed. In press, doi: 10.1002/anie.201602145.
- G. Palermo, A. Magistrato, T. Riedel, T. von Erlach, C.A. Davey, P.J. Dyson & U. Rothlisberger. 2016. Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies. ChemMedChem. In press, doi: 10.1002/cmdc.201500478.
- R.F. Lee, S. Escrig, M. Croisier, S. Clerc-Rosset, G.W. Knott, A. Meibom, C.A. Davey, K. Johnsson & P.J. Dyson. 2015. NanoSIMS Analysis of an Isotopically Labelled Organometallic Ruthenium(II) Drug to Probe Its Distribution and State In Vitro. Chem. Commun. 51(92): 16,486-16,489.